CAN, Ö. Et Al. 2014. Quantification of fibrin degradation products in glioma and meningioma patients. CANCER BIOMARKERS , vol.14, no.4 , 253-258.

CAN, Ö., Erdemgil, Y., Yildirim, Z. Z., ÖZDUMAN, K., Pamir, M. N., Sav, A., ... ÖZPINAR, A.(2014). Quantification of fibrin degradation products in glioma and meningioma patients. CANCER BIOMARKERS , vol.14, no.4, 253-258.

CAN, ÖZGE Et Al. "Quantification of fibrin degradation products in glioma and meningioma patients," CANCER BIOMARKERS , vol.14, no.4, 253-258, 2014

CAN, ÖZGE Et Al. "Quantification of fibrin degradation products in glioma and meningioma patients." CANCER BIOMARKERS , vol.14, no.4, pp.253-258, 2014

CAN, Ö. Et Al. (2014) . "Quantification of fibrin degradation products in glioma and meningioma patients." CANCER BIOMARKERS , vol.14, no.4, pp.253-258.

@article{article, author={ÖZGE CAN Et Al. }, title={Quantification of fibrin degradation products in glioma and meningioma patients}, journal={CANCER BIOMARKERS}, year=2014, pages={253-258} }